vs

Side-by-side financial comparison of GERON CORP (GERN) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.

GERON CORP is the larger business by last-quarter revenue ($47.2M vs $41.3M, roughly 1.1× Northfield Bancorp, Inc.). GERON CORP runs the higher net margin — -39.0% vs -1545.5%, a 1506.5% gap on every dollar of revenue. On growth, GERON CORP posted the faster year-over-year revenue change (67.1% vs 12.7%). Over the past eight quarters, GERON CORP's revenue compounded faster (1597.0% CAGR vs 15.0%).

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.

GERN vs NFBK — Head-to-Head

Bigger by revenue
GERN
GERN
1.1× larger
GERN
$47.2M
$41.3M
NFBK
Growing faster (revenue YoY)
GERN
GERN
+54.4% gap
GERN
67.1%
12.7%
NFBK
Higher net margin
GERN
GERN
1506.5% more per $
GERN
-39.0%
-1545.5%
NFBK
Faster 2-yr revenue CAGR
GERN
GERN
Annualised
GERN
1597.0%
15.0%
NFBK

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GERN
GERN
NFBK
NFBK
Revenue
$47.2M
$41.3M
Net Profit
$-18.4M
$-27.4M
Gross Margin
Operating Margin
-29.4%
-1263.3%
Net Margin
-39.0%
-1545.5%
Revenue YoY
67.1%
12.7%
Net Profit YoY
30.3%
-343.6%
EPS (diluted)
$-0.03
$-0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GERN
GERN
NFBK
NFBK
Q4 25
$41.3M
Q3 25
$47.2M
$39.2M
Q2 25
$49.0M
$38.9M
Q1 25
$39.6M
$34.8M
Q4 24
$36.7M
Q3 24
$28.3M
$31.8M
Q2 24
$882.0K
$31.5M
Q1 24
$304.0K
$31.3M
Net Profit
GERN
GERN
NFBK
NFBK
Q4 25
$-27.4M
Q3 25
$-18.4M
$10.8M
Q2 25
$-16.4M
$9.6M
Q1 25
$-19.8M
$7.9M
Q4 24
$11.3M
Q3 24
$-26.4M
$6.5M
Q2 24
$-67.4M
$6.0M
Q1 24
$-55.4M
$6.2M
Operating Margin
GERN
GERN
NFBK
NFBK
Q4 25
-1263.3%
Q3 25
-29.4%
37.7%
Q2 25
-25.4%
35.6%
Q1 25
-42.2%
31.0%
Q4 24
38.0%
Q3 24
-99.8%
27.9%
Q2 24
-7860.9%
29.1%
Q1 24
-18465.1%
27.2%
Net Margin
GERN
GERN
NFBK
NFBK
Q4 25
-1545.5%
Q3 25
-39.0%
27.4%
Q2 25
-33.4%
24.6%
Q1 25
-50.1%
22.6%
Q4 24
30.7%
Q3 24
-93.5%
20.5%
Q2 24
-7639.8%
18.9%
Q1 24
-18220.4%
19.9%
EPS (diluted)
GERN
GERN
NFBK
NFBK
Q4 25
$-0.68
Q3 25
$-0.03
$0.27
Q2 25
$-0.02
$0.24
Q1 25
$-0.03
$0.19
Q4 24
$0.27
Q3 24
$-0.04
$0.16
Q2 24
$-0.10
$0.14
Q1 24
$-0.09
$0.15

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GERN
GERN
NFBK
NFBK
Cash + ST InvestmentsLiquidity on hand
$78.1M
$164.0M
Total DebtLower is stronger
Stockholders' EquityBook value
$248.7M
$690.1M
Total Assets
$567.4M
$5.8B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GERN
GERN
NFBK
NFBK
Q4 25
$164.0M
Q3 25
$78.1M
$131.7M
Q2 25
$77.7M
$97.6M
Q1 25
$83.7M
$101.7M
Q4 24
$167.7M
Q3 24
$60.3M
$232.9M
Q2 24
$116.9M
$153.5M
Q1 24
$189.8M
$238.8M
Total Debt
GERN
GERN
NFBK
NFBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$666.4M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GERN
GERN
NFBK
NFBK
Q4 25
$690.1M
Q3 25
$248.7M
$719.6M
Q2 25
$259.5M
$710.3M
Q1 25
$268.2M
$711.1M
Q4 24
$704.7M
Q3 24
$292.3M
$699.6M
Q2 24
$306.7M
$693.0M
Q1 24
$344.9M
$698.4M
Total Assets
GERN
GERN
NFBK
NFBK
Q4 25
$5.8B
Q3 25
$567.4M
$5.7B
Q2 25
$555.2M
$5.7B
Q1 25
$562.5M
$5.7B
Q4 24
$5.7B
Q3 24
$444.9M
$5.7B
Q2 24
$449.4M
$5.7B
Q1 24
$482.1M
$5.9B
Debt / Equity
GERN
GERN
NFBK
NFBK
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.95×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GERN
GERN
NFBK
NFBK
Operating Cash FlowLast quarter
$-13.6M
$53.7M
Free Cash FlowOCF − Capex
$52.5M
FCF MarginFCF / Revenue
127.1%
Capex IntensityCapex / Revenue
2.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$89.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GERN
GERN
NFBK
NFBK
Q4 25
$53.7M
Q3 25
$-13.6M
$13.9M
Q2 25
$-27.4M
$14.1M
Q1 25
$-48.0M
$9.4M
Q4 24
$31.1M
Q3 24
$-58.9M
$14.0M
Q2 24
$-53.5M
$6.9M
Q1 24
$-62.3M
$4.2M
Free Cash Flow
GERN
GERN
NFBK
NFBK
Q4 25
$52.5M
Q3 25
$13.6M
Q2 25
$13.9M
Q1 25
$9.2M
Q4 24
$30.0M
Q3 24
$13.7M
Q2 24
$-53.7M
$6.7M
Q1 24
$-62.9M
$3.8M
FCF Margin
GERN
GERN
NFBK
NFBK
Q4 25
127.1%
Q3 25
34.6%
Q2 25
35.7%
Q1 25
26.3%
Q4 24
81.6%
Q3 24
43.2%
Q2 24
-6086.6%
21.1%
Q1 24
-20680.3%
12.1%
Capex Intensity
GERN
GERN
NFBK
NFBK
Q4 25
2.8%
Q3 25
0.8%
Q2 25
0.6%
Q1 25
0.7%
Q4 24
3.1%
Q3 24
0.0%
0.7%
Q2 24
23.4%
0.8%
Q1 24
202.3%
1.4%
Cash Conversion
GERN
GERN
NFBK
NFBK
Q4 25
Q3 25
1.29×
Q2 25
1.48×
Q1 25
1.20×
Q4 24
2.76×
Q3 24
2.14×
Q2 24
1.16×
Q1 24
0.68×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons